BIRMF (Biorem) Total Equity: $11.15 Mil (As of Mar. 2026)


BIRMF Biorem Inc BIRMF
88 GF Score
Price $2.19
GF Value $1.93
Valuation Modestly Overvalued
View Full Analysis

What is Biorem Total Equity?

Biorem BIRMF +0.39% 88 Total Equity is $11.15 Mil as of Mar. 2026. GuruFocus rates BIRMF with a GF Score™ of 88/100 and a GF Value™ of $1.93 (Modestly Overvalued).

Biorem's total equity for the quarter that ended in Mar. 2026 was $11.15 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Biorem Total Equity Historical Data

* Premium members only.

The historical data trend for Biorem's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biorem Total Equity Chart

Biorem Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.53 3.33 5.01 7.46 10.82

Biorem Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.45 8.01 8.82 10.82 11.15
BIRMF
88GF Score
Biorem Inc BIRMF
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biorem Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Biorem's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=24.339-13.52
=10.82

Biorem's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=22.991-11.842
=11.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $11.15 Mil mean?
Biorem (BIRMF) has a Total Equity of $11.15 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Biorem and its competitors.
Is Biorem's Total Equity too high?
Biorem's current Total Equity is $11.15 Mil. Overall, Biorem has a GF Score™ of 88/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Biorem's Total Equity compare to VLTO and ZWS?
Biorem's Total Equity of $11.15 Mil can be compared against companies in the Industrial Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for an Industrial Products company?
A good Total Equity depends on the Industrial Products industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Biorem and its competitors. Biorem's current Total Equity is $11.15 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biorem stock overvalued right now?
Based on GuruFocus' analysis, Biorem (BIRMF) is currently considered Modestly Overvalued. The stock's GF Value™ is $1.93, compared to a current price of $2.19 — trading 13.5% above its estimated fair value. The current Total Equity is $11.15 Mil. Biorem's overall GF Score™ is 88/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Biorem (BIRMF), the current Total Equity is $11.15 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Biorem (BIRMF) Overvalued in 2026?

Based on GuruFocus' analysis, Biorem stock appears to be overvalued. The current stock price of $2.19 is trading 13.5% above its estimated GF Value™ of $1.93. GuruFocus considers Biorem to be Modestly Overvalued.

Key valuation signals for BIRMF:

  • Total Equity: $11.15 Mil
  • GF Value™: $1.93 vs. price of $2.19 (13.5% above fair value)
  • GF Score™: 88/100

No single metric tells the full story. See the BIRMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Biorem Business Description

Other Exchanges R6D:GermanyBRM:Canada
Address 7496 Wellington Road 34, RR Number 3, Puslinch, Guelph, ON, CAN, N1H 6H9
Biorem Inc is an environmental biotechnology company. It is involved in the manufacturing of a comprehensive line of high efficiency air pollution control systems that are used to eliminate odorous and harmful contaminants. The company's products include Biofilters, Biogas Solutions, Multi-Stage Systems, Biotrickling filters, and services such as Media Sampling and Analysis, Biological processes and testing, Media replacements and Spare parts, and other related services. The company derives revenues from the sale of standard products, construction projects for specialized products, and services for repairs and maintenance. The group has a business presence in Canada, the United States, China and others, of which key revenue is derived from the United States.
88GF Score

Get the complete analysis for BIRMF

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.19
Price
$1.93
GF Value